搜索筛选:
搜索耗时2.3952秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
类      型:
[期刊论文] 作者:Yu-Quan Wei,, 来源:Science China(Life Sciences) 年份:2016
The development of genetic engineering has enabled the modification of stem cells and somatic cells.T cells exert immune responses against cancer cells.Efforts...
[期刊论文] 作者:Yu-Quan Wei, 来源:中国科学:生命科学英文版 年份:2017
MicroRNAs(miRNAs)constitute a class of small non-coding RNAs that participate in various biological processes by repressing protein translation or destabili...
[会议论文] 作者:Xianghui Fu,Yu-quan Wei, 来源:2015国际代谢科学大会(International Conference on Metabolic Sciences 年份:2015
[期刊论文] 作者:Niu Yu-Quan,Wei Wei,Zheng Bin,Zhang Cai-Xia,Meng Qing-Tian, 来源:中国物理B(英文版) 年份:2013
[期刊论文] 作者:Wei Wang,Di-Yuan Qin,Bing-Lan Zhang,Wei Wei,Yong-Sheng Wang,Yu-Quan Wei,, 来源:Science China(Life Sciences) 年份:2016
T cells, genetically modified by chimeric antigen receptors(CAR-T), are endowed with specificity to a desired antigen and are cytotoxic to cells expressing the...
[期刊论文] 作者:Shu-Lan Yuan,Yu-Quan Wei,Xiu-Jie Wang,Fei XIAO,Sheng-Fu Li,Jie Zhang, 来源:世界胃肠病学杂志(英文版) 年份:2004
AIM: To evaluate the effects of tanshinone Ⅱ-A on inducing growth inhibition and apoptosis of human hepatocellular carcinoma (HCC) cells.METHODS: The human hep...
[期刊论文] 作者:Bing-Lan Zhang,Di-Yuan Qin,Ze-Ming Mo,Yi Li,Wei Wei,Yong-Sheng Wang,Wei Wang,Yu-Quan Wei,, 来源:Science China(Life Sciences) 年份:2016
Recent reports on the impressive efficacy of chimeric antigen receptor(CAR)-modified T cells against hematologic malignancies have inspired oncologists to exten...
[期刊论文] 作者:Jian-mei HOU,Xia ZHAO,Ling TIAN,Gang LI,gu ZHANG,Bing YAO,Hong-xin DENG,Jin-liang YANG,Yu-quan WEI, 来源:中国药理学报(英文版) 年份:2009
Aim: Tumor immunotherapy aims at activating the body’s own immune system to fight an existing tumor. Effective antitumor responses require tumor antigens to be...
[期刊论文] 作者:Wang,Chong-Yang Deng,Hao Zheng,Xian-Huo Wang,Liang Ma,Xia Ye,Ying-Hua Ma,Cai-Feng Xie,Li-Juan Chen,Yu-Quan Wei, 来源:世界胃肠病学杂志(英文版) 年份:2012
相关搜索: